↓ Skip to main content

Michigan Publishing

Article Metrics

Interim Estimates of 2017–18 Seasonal Influenza Vaccine Effectiveness — United States, February 2018

Overview of attention for article published in MMWR: Morbidity & Mortality Weekly Report, February 2018
Altmetric Badge

About this Attention Score

  • In the top 5% of all research outputs scored by Altmetric
  • One of the highest-scoring outputs from this source (#6 of 1,863)
  • High Attention Score compared to outputs of the same age (99th percentile)
  • High Attention Score compared to outputs of the same age and source (99th percentile)

Mentioned by

news
110 news outlets
blogs
6 blogs
policy
1 policy source
twitter
811 tweeters
facebook
22 Facebook pages
wikipedia
1 Wikipedia page
googleplus
5 Google+ users
reddit
4 Redditors

Citations

dimensions_citation
20 Dimensions

Readers on

mendeley
27 Mendeley
Title
Interim Estimates of 2017–18 Seasonal Influenza Vaccine Effectiveness — United States, February 2018
Published in
MMWR: Morbidity & Mortality Weekly Report, February 2018
DOI 10.15585/mmwr.mm6706a2
Pubmed ID
Authors

Brendan Flannery

Abstract

In the United States, annual vaccination against seasonal influenza is recommended for all persons aged ≥6 months (1). During each influenza season since 2004-05, CDC has estimated the effectiveness of seasonal influenza vaccine to prevent laboratory-confirmed influenza associated with medically attended acute respiratory illness (ARI). This report uses data from 4,562 children and adults enrolled in the U.S. Influenza Vaccine Effectiveness Network (U.S. Flu VE Network) during November 2, 2017-February 3, 2018. During this period, overall adjusted vaccine effectiveness (VE) against influenza A and influenza B virus infection associated with medically attended ARI was 36% (95% confidence interval [CI] = 27%-44%). Most (69%) influenza infections were caused by A(H3N2) viruses. VE was estimated to be 25% (CI = 13% to 36%) against illness caused by influenza A(H3N2) virus, 67% (CI = 54%-76%) against A(H1N1)pdm09 viruses, and 42% (CI = 25%-56%) against influenza B viruses. These early VE estimates underscore the need for ongoing influenza prevention and treatment measures. CDC continues to recommend influenza vaccination because the vaccine can still prevent some infections with currently circulating influenza viruses, which are expected to continue circulating for several weeks. Even with current vaccine effectiveness estimates, vaccination will still prevent influenza illness, including thousands of hospitalizations and deaths. Persons aged ≥6 months who have not yet been vaccinated this season should be vaccinated.

Twitter Demographics

The data shown below were collected from the profiles of 811 tweeters who shared this research output. Click here to find out more about how the information was compiled.

Mendeley readers

The data shown below were compiled from readership statistics for 27 Mendeley readers of this research output. Click here to see the associated Mendeley record.

Geographical breakdown

Country Count As %
Unknown 27 100%

Demographic breakdown

Readers by professional status Count As %
Unspecified 12 44%
Researcher 11 41%
Student > Master 7 26%
Student > Ph. D. Student 6 22%
Student > Doctoral Student 5 19%
Other 10 37%
Readers by discipline Count As %
Unspecified 15 56%
Medicine and Dentistry 13 48%
Biochemistry, Genetics and Molecular Biology 4 15%
Nursing and Health Professions 4 15%
Agricultural and Biological Sciences 3 11%
Other 12 44%

Attention Score in Context

This research output has an Altmetric Attention Score of 1557. This is our high-level measure of the quality and quantity of online attention that it has received. This Attention Score, as well as the ranking and number of research outputs shown below, was calculated when the research output was last mentioned on 06 July 2018.
All research outputs
#968
of 11,627,193 outputs
Outputs from MMWR: Morbidity & Mortality Weekly Report
#6
of 1,863 outputs
Outputs of similar age
#80
of 330,722 outputs
Outputs of similar age from MMWR: Morbidity & Mortality Weekly Report
#1
of 123 outputs
Altmetric has tracked 11,627,193 research outputs across all sources so far. Compared to these this one has done particularly well and is in the 99th percentile: it's in the top 5% of all research outputs ever tracked by Altmetric.
So far Altmetric has tracked 1,863 research outputs from this source. They typically receive a lot more attention than average, with a mean Attention Score of 71.7. This one has done particularly well, scoring higher than 99% of its peers.
Older research outputs will score higher simply because they've had more time to accumulate mentions. To account for age we can compare this Altmetric Attention Score to the 330,722 tracked outputs that were published within six weeks on either side of this one in any source. This one has done particularly well, scoring higher than 99% of its contemporaries.
We're also able to compare this research output to 123 others from the same source and published within six weeks on either side of this one. This one has done particularly well, scoring higher than 99% of its contemporaries.